Given the pivotal role of CD8+ T cells in the anti-tumor immune response [39, 40], it is postulated that MED1 may modulate PD-L1 expression via the Notch signaling pathway, leading to the suppression of CD8+ T cell function, thereby facilitating immune evasion and ultimately promoting tumor progression. The gene discussed is MED1; the disease is neoplasm.